Eurovision scrambles to ensure Russia’s participation in Kiev-hosted song contestSociety & Culture March 27, 11:41
Siberian ex-cop turned sadistic ‘werewolf’ serial killer charged with another 60 murdersSociety & Culture March 27, 11:25
NATO-Russia Council meeting on the horizon – diplomatRussian Politics & Diplomacy March 27, 11:06
Russia’s FSB detains gunmakers, seizes three aircraft gunsRussian Politics & Diplomacy March 27, 10:32
Russian, Tajik troops hold joint anti-terror drills in AsiaMilitary & Defense March 27, 9:11
US calls for release of detained participants in unsanctioned rallies across RussiaWorld March 27, 6:37
Russia conducts six humanitarian operations in Syria in 24 hoursSociety & Culture March 27, 6:34
Talks on banning nuclear weapons begin in UN without Russia, USWorld March 27, 6:28
Meeting with Putin of exceptional importance for Serbia — premierWorld March 27, 4:16
The trials are set to start in Switzerland’s Lausanne late this month or on the first day of the next month. A total of 125 volunteers are to be injected two various doses of chimpanzee-based adenovirus vaccine, she said.
Clinical tests of this vaccine are already underway in the United States, the United Kingdom and Mali, in West Africa.Simultaneously, Geneva is due to carry out clinical trials of a second vaccine, containing a recombinant vesicular stomatitis virus. Five various doses of the vaccine are to be tested in Geneva. The trials will also involve 125 volunteers.
These tests will last for between 6 months and one year, but the first results on their safety and antigenicity will be ready in December. If the vaccine proves to be successful, it will be delivered to the West African states in January 2015.
Kieny said there is yet no talk of a massive vaccination. Some 10,000 people are expected to be vaccinated, she added.
The World Health Organization (WHO) reported last week that the Ebola epidemic was spreading geographically and the death toll exceeds 4,500, while the number of probable and suspected cases nears 9,000.